Skip to main content
Federal Court of Appeal· 2001

Novartis Pharmaceuticals Canada Inc. v. Rhoxalpharma Inc.

2001 FCA 371
GeneralJD
Cite or share
Share via WhatsAppEmail
Showing the official court-reporter headnote. An editorial brief (facts · issues · held · ratio · significance) is on the roadmap for this case. The judgment text below is the authoritative source.

Court headnote

Novartis Pharmaceuticals Canada Inc. v. Rhoxalpharma Inc. Court (s) Database Federal Court of Appeal Decisions Date 2001-11-28 Neutral citation 2001 FCA 371 File numbers A-195-01 Decision Content Date: 20011128 Docket: A-195-01 Neutral citation: 2001 FCA 371 CORAM: RICHARD C.J. DÉCARY J.A. LINDEN J.A. BETWEEN: NOVARTIS PHARMACEUTICALS CANADA INC. and NOVARTIS AG Appellants (Applicants) and RHOXALPHARMA INC. and THE MINISTER OF HEALTH Respondents (Respondents) Heard at Ottawa, Ontario, on November 28, 2001. Judgment delivered from the Bench at Ottawa, Ontario, on November 28, 2001. REASONS FOR JUDGMENT OF THE COURT BY: RICHARD C.J. Date: 20011128 Docket: A-195-01 Neutral citation: 2001 FCA 371 CORAM: RICHARD C.J. DÉCARY J.A. LINDEN J.A. BETWEEN: NOVARTIS PHARMACEUTICALS CANADA INC. and NOVARTIS AG Appellants (Applicants) and RHOXALPHARMA INC. and THE MINISTER OF HEALTH Respondents (Respondents) REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Ottawa, Ontario on November 28, 2001.) RICHARD C.J. [1] We are of the view, based on the decision of this Court in Pfizer Canada Inc. v. Apotex Inc., (2001) 11 C.P.R. (4th) 245 (F.C.A.); motion for leave to appeal dismissed, Supreme Court of Canada Bulletin of Proceedings, September 28, 2001, that the motion to dismiss the appeal on the ground that the appeal is moot should be allowed and, accordingly, the appeal will be dismissed with costs to Rhoxalpharma Inc. "J. Richard" Chief Justice …

Read full judgment
Novartis Pharmaceuticals Canada Inc. v. Rhoxalpharma Inc.
Court (s) Database
Federal Court of Appeal Decisions
Date
2001-11-28
Neutral citation
2001 FCA 371
File numbers
A-195-01
Decision Content
Date: 20011128
Docket: A-195-01
Neutral citation: 2001 FCA 371
CORAM: RICHARD C.J.
DÉCARY J.A.
LINDEN J.A.
BETWEEN:
NOVARTIS PHARMACEUTICALS CANADA INC.
and NOVARTIS AG
Appellants
(Applicants)
and
RHOXALPHARMA INC. and
THE MINISTER OF HEALTH
Respondents
(Respondents)
Heard at Ottawa, Ontario, on November 28, 2001.
Judgment delivered from the Bench at Ottawa, Ontario, on November 28, 2001.
REASONS FOR JUDGMENT OF THE COURT BY: RICHARD C.J.
Date: 20011128
Docket: A-195-01
Neutral citation: 2001 FCA 371
CORAM: RICHARD C.J.
DÉCARY J.A.
LINDEN J.A.
BETWEEN:
NOVARTIS PHARMACEUTICALS CANADA INC.
and NOVARTIS AG
Appellants
(Applicants)
and
RHOXALPHARMA INC. and
THE MINISTER OF HEALTH
Respondents
(Respondents)
REASONS FOR JUDGMENT OF THE COURT
(Delivered from the Bench at Ottawa, Ontario
on November 28, 2001.)
RICHARD C.J.
[1] We are of the view, based on the decision of this Court in Pfizer Canada Inc. v. Apotex Inc., (2001) 11 C.P.R. (4th) 245 (F.C.A.); motion for leave to appeal dismissed, Supreme Court of Canada Bulletin of Proceedings, September 28, 2001, that the motion to dismiss the appeal on the ground that the appeal is moot should be allowed and, accordingly, the appeal will be dismissed with costs to Rhoxalpharma Inc.
"J. Richard"
Chief Justice

Source: decisions.fca-caf.gc.ca

Related cases